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FOXM1 targets NBS1 to regulate DNA damage-induced
senescence and epirubicin resistance
P Khongkow1, U Karunarathna1, M Khongkow1, C Gong1,2, AR Gomes1, E Yagu¨e1, LJ Monteiro1, M Kongsema1, S Zona1, EPS Man2,
JW-H Tsang3, RC Coombes1, K-J Wu4, U-S Khoo2, RH Medema5, R Freire6 and EW-F Lam1
FOXM1 is implicated in genotoxic drug resistance but its mechanism of action remains elusive. We show here that FOXM1-
depletion can sensitize breast cancer cells and mouse embryonic ﬁbroblasts (MEFs) into entering epirubicin-induced senescence,
with the loss of long-term cell proliferation ability, the accumulation of gH2AX foci, and the induction of senescence-associated
b-galactosidase activity and cell morphology. Conversely, reconstitution of FOXM1 in FOXM1-deﬁcient MEFs alleviates the
accumulation of senescence-associated gH2AX foci. We also demonstrate that FOXM1 regulates NBS1 at the transcriptional level
through an forkhead response element on its promoter. Like FOXM1, NBS1 is overexpressed in the epirubicin-resistant MCF-7EpiR
cells and its expression level is low but inducible by epirubicin in MCF-7 cells. Consistently, overexpression of FOXM1 augmented
and FOXM1 depletion reduced NBS1 expression and epirubicin-induced ataxia-telangiectasia mutated (ATM)phosphorylation in
breast cancer cells. Together these ﬁndings suggest that FOXM1 increases NBS1 expression and ATM phosphorylation, possibly
through increasing the levels of the MRN(MRE11/RAD50/NBS1) complex. Consistent with this idea, the loss of P-ATM induction by
epirubicin in the NBS1-deﬁcient NBS1-LBI ﬁbroblasts can be rescued by NBS1 reconstitution. Resembling FOXM1, NBS1 depletion
also rendered MCF-7 and MCF-7EpiR cells more sensitive to epirubicin-induced cellular senescence. In agreement, the DNA
repair-defective and senescence phenotypes in FOXM1-deﬁcent cells can be effectively rescued by overexpression of NBS1.
Moreover, overexpression of NBS1 and FOXM1 similarly enhanced and their depletion downregulated homologous recombination
(HR) DNA repair activity. Crucially, overexpression of FOXM1 failed to augment HR activity in the background of NBS1 depletion,
demonstrating that NBS1 is indispensable for the HR function of FOXM1. The physiological relevance of the regulation of
NBS1 expression by FOXM1 is further underscored by the strong and signiﬁcant correlation between nuclear FOXM1 and total NBS1
expression in breast cancer patient samples, further suggesting that NBS1 as a key FOXM1 target gene involved in DNA damage
response, genotoxic drug resistance and DNA damage-induced senescence.
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INTRODUCTION
Breast cancer is the most common malignancy among women
worldwide, as well as one of the leading causes of cancer death.
Genotoxic drugs, including anti-metabolites, topoisomerase
inhibitors, and anthracyclines as well as radiotherapy are used
universally in the treatment of breast cancer and to reduce the
chance of metastasis. These therapeutic agents are particularly
important for the treatment of breast cancers that are not suitable
for or refractory to endocrine therapies. Anthracyclines, including
epirubicin, are anti-cancer antibiotics that have proven efﬁcacy in
the treatment of breast, lung and ovarian cancers as well as
leukaemia.1 The primary mechanism of action of anthracyclines is
to interfere with enzymes involved in DNA replication, but these
drugs can also induce DNA intercalation and damage, which will
ultimately result in DNA lesions primarily in the forms of double-
stranded breaks (DSBs). The cellular response to DNA damage, the
so-called ‘DNA damage response’, involves the recognition of DNA
damage, the activation of cell cycle checkpoints, transcription
programmes, DNA damage repair, and senescence and apoptosis,
if the damage is irreparable.2
DSBs are predominantly repaired by two mechanisms, homo-
logous recombination (HR) and non-homologous end joining.3
Ataxia-telangiectasia mutated (ATM) is a phosphatidylinositol
3-kinase-related kinase central to the DNA damage response
signalling and is activated upon DNA damage by DSBs. Its
activation, accompanied by autophosphorylation on serine 1981
(P-ATM), induces phosphorylation of its downstream target
histone H2AX, leading ultimately to the recruitment of DNA
repair proteins to the sites of damage.4 In addition, the ATM kinase
also directly phosphorylates modulator proteins, including
p53BP1, SMC1, BRCA1, NBS1 and CHK2, essential for triggering
cell-cycle arrest, apoptosis and DNA repair.5–8 The MRN (MRE11/
RAD50/NBS1) complex has a key role in sensing DSBs and in
the activation of ATM.7 The assembly of the MRN complex is a
rate-limiting step for the recruitment of the ATM and its phospho-
rylation, and therefore, the activation of the DNA damage repair
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response.9 In particular, ATM is dependent on NBS1 as part of the
MRN complex for sensing DSBs, and also as an adaptor molecule
for phosphorylation of its downstream substrates.10,11
Cellular senescence is an intrinsic cellular response that restricts
unlimited cell proliferation and has a key physiological role
in tumour suppression through preventing cancer initiation
and progression.12 Cells can be induced to undergo premature
senescence by intracellular as well as extracellular stress including
irradiation, persistent DNA damage response, oncogene acti-
vation, telomere erosion, oxidative stress, toxins and stem cell
reprogramming.13 FOXM1 is a member of the Forkhead box (FOX)
superfamily of transcription factors that share a conserved
winged-helix DNA-binding domain.14 It is ubiquitously expressed
in actively proliferating tissues and has a crucial role in a wide
range of biological processes, including cell cycle progression,
angiogenesis, metastasis, apoptosis, tissue regeneration and drug
resistance. We have obtained evidence that FOXM1 can protect
cells from genotoxic agent-induced senescence by enhancing HR
DNA repair. Consistently, FOXM1 is overexpressed in genotoxic
agent-resistant cancer cells. In here, we studied the role of
FOXM1 in genotoxic drug resistance and found that FOXM1
regulates NBS1 expression to modulate HR DNA damage repair,
which has a role in overcoming DNA damage agent-induced
cellular senescence.
RESULTS
FOXM1 deletion decreases long-term viability and activates
cellular senescence in response to DNA damage
Recent evidence shows that FOXM1 can protect cells from
genotoxic agent-induced cell death by enhancing DNA damage
repair.15–17 However, the role of FOXM1 in promoting long-term cell
viability in response to genotoxic treatment has not been evaluated.
To address this, we treated wild-type (WT) and Foxm1 / MEFs
with a range of concentrations of epirubicin and studied their long-
term viability by clonogenic assays (Supplementary Figure S1). The
results showed that at 0, 20 and 40nM epirubicin, the colony
formation capacity of Foxm1 / MEFs was signiﬁcantly impaired
compared with WT MEFs (Figure 1a). To conﬁrm this further, WT and
Foxm1 / MEFs were also exposed to moderate levels of ionizing
radiation (Figure 1b). At 5Gy g-irradiation, the colony formation
capacity of Foxm1 / MEFs was signiﬁcantly reduced compared
with WT MEFs. As these low epirubicin concentrations and ionizing
irradiation doses do not induce considerable cell death,15 we
reasoned that epirubicin might induce long-term proliferative arrest,
implicative of cellular senescence. To test this conjecture, WT and
Foxm1 / MEFs were assayed for senescence-associated
b-galactosidase (SAb-gal) activity following low doses of epirubicin
treatment (Figure 1c). At 20 and 40nM epirubicin treatment,
signiﬁcantly higher numbers of Foxm1 / MEFs displayed distinct
SAb-gal activity and ‘ﬂat cell’ morphology compared with WT MEFs,
suggesting that FOXM1 has a key role in DNA damage-induced
senescence. Moreover, signiﬁcantly higher numbers of Foxm1 /
MEFs displayed SAb-gal and senescent morphology compared with
WT MEFs following exposure to 5Gy of g-irradiation (Figure 1d).
Senescent cells accumulate gH2AX foci as markers for unrepaired or
irreparable damaged DNA.18 We also found that Foxm1 / MEFs
accumulated signiﬁcantly higher numbers of gH2AX foci compared
with WT MEFs at prolonged times of 24, 48 and 72h following
epirubicin treatment, suggesting that FOXM1 deletion renders MEFs
more susceptible to the accumulation of DSBs induced by
genotoxic agents (Supplementary Figure S2).
FOXM1 depletion resensitizes MCF-7 breast cancer cells to
epirubicin-induced cellular senescence
We next studied the effects of FOXM1 depletion by small
interfering RNA (siRNA) on the long-term viability of MCF-7 and
the epirubicin-resistant MCF-7EpiR breast cancer cell lines by
clonogenic assays (Figure 2). FOXM1-knockdown sensitized MCF-7
cells to long-term proliferative arrest at relatively low epirubicin
concentrations (for example, 10 and 20 nM; Figure 2a), whereas at
higher concentrations (420 nM) the colony formation ability was
completely lost in MCF-7 cells (data not shown). FOXM1 depletion
alone almost completely abolished the colony formation ability of
MCF-7EpiR cells irrespective of the dosage of epirubicin used,
suggesting that MCF-7EpiR cells are dependent on high FOXM1
expression for long-term survival (Figure 2b). In addition, similar to
what it occur in MEFs, FOXM1 knockdown in MCF-7 cells
enhanced the number of cells exhibiting SAb-gal activity and
morphology at 0 and 10 nM epirubicin (Figure 2c). Consistent with
previous results, FOXM1 knockdown in MCF-7EpiR cells resulted in
almost all cells displaying senescence-associated SAb-gal activity
and morphology independent of epirubicin levels, suggesting
MCF-7EpiR cells have become dependent on FOXM1 to override
senescence (Figure 2d). Senescent cells accumulate gH2AX foci as
markers for unrepaired or irreparable damaged DNA.18 To conﬁrm
this further, we studied the effects of FOXM1 depletion on nuclear
gH2AX foci formation in MCF-7 and MCF-7EpiR cells following
g-irradiation (Figures 3a and b). Quantiﬁcation of gH2AX foci
showed that g-irradiation induced the accumulation of signi-
ﬁcantly more foci over the extended time course of 24, 48 and
72 h in FOXM1-knockdown cells in comparison to control siRNA-
transfected MCF-7 and MCF-7EpiR cells, further indicating that
FOXM1 has a critical role in overcoming DNA damage-induced
senescence.
FOXM1 enhances NBS1 and P-ATM expression to promote DNA
damage repair signalling
We have shown previously that FOXM1 is essential for HR repair
after DSBs.17 To elucidate the underlying mechanistic role of
FOXM1 in DNA damage-induced senescence and epirubicin
resistance, we next compared the expression patterns of FOXM1
with those of the early HR sensor proteins, including ATM and
components of the MRN (MRE11/RAD50/NBS1; NBS1 also known as
Nibrin and NBN) complex in MCF-7 and MCF-7EpiR cells in response
to epirubicin. Western blot analysis showed that the expression
level of FOXM1 protein was induced transiently before declining
eventually following epirubicin treatment in MCF-7 cells, whereas
FOXM1 was expressed consistently at high levels in the resistant
MCF-7EpiR cells (Figure 4a). ATM was expressed at higher levels
in MCF-7EpiR compared with the control MCF-7 cells. Auto-
phosphorylated ATM (P-ATM), indicative of ATM activity, was
constitutively high in MCF-7EpiR cells, whereas the P-ATM signal
was low but inducible by epirubicin in MCF-7 cells. NBS1 as well as
its active phosphorylated form P-NBS1 followed similar kinetics as
FOXM1 upon epirubicin treatment in both MCF-7 and MCF-7EpiR
cells (Figure 4a; Supplementary Figure S3), suggesting the
regulation of NBS1 expression and activity by FOXM1. By contrast,
the other MRN components, MRE11 and RAD50, did not show
substantial correlation with the expression patterns of FOXM1
upon epirubicin treatment. Consistently, quantitative real-time PCR
(qRT–PCR) analysis revealed that upon epirubicin treatment the
NBS1 and FOXM1 mRNA displayed similar kinetics in both MCF-7
and MCF-7EpiR cells, further suggesting FOXM1 may transcription-
ally regulate NBS1 expression (Figure 4b). To test this idea, both
MCF-7 and MCF-7EpiR cells were transfected with non-targeting
control (non-speciﬁc (NS)) or FOXM1 siRNA pools for 24 h and were
subjects to western blot and qRT–PCR analyses after incubation
with epirubicin or vehicle control for another 24 h. Silencing the
expression of FOXM1 caused a signiﬁcant reduction in the NBS1
protein and mRNA levels in both MCF-7 and MCF-7EpiR cells,
whereas only a moderate decrease was observed for the RAD50
and MRE11 protein, but not at the mRNA level, upon FOXM1
knockdown (Figures 4c and d; Supplementary Figure S4).
FOXM1 regulates NBS1 and senescence
P Khongkow et al
4145
& 2014 Macmillan Publishers Limited Oncogene (2014) 4144 – 4155
This suggests that in contrast to NBS1, RAD50 and MRE11 are not
directly regulated by FOXM1, raising the possibility that their
protein expression levels might be stabilized through forming
an active MRN complex. Notably, the expression of P-ATM and
P-CHK2 was induced in MCF-7 and MCF-7EpiR cells after epirubicin
treatment. This is likely to reﬂect the genotoxic stress response
of the cells after epirubicin treatment following the serum
starvation conditions used for siRNA transfection. These stress
conditions might also be responsible for the high levels of cell
death and global protein degradation observed in the MCF-7
cells. It is also noteworthy that P-ATM levels were induced by
epirubicin treatment, but this induction was abolished upon
FOXM1 depletion by siRNA, suggesting FOXM1 is involved in
the activation of ATM. Similar results were also observed for the
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Figure 1. FOXM1 deletion inhibits colony formation and induces cellular senescence in response to DNA damage in MEFs. (a) Clonogenic
assays were performed to assess the colony formation efficiency of Foxm1 / and WT MEFs. A total of 2000 cells were seeded in six-well
plates, treated with 0, 20 and 40nM of epirubicin and grown for 15 days. The cells were then stained with crystal violet (left panel). The result
(right panel) represents average of three independent experiments±s.d. Statistical significance was determined by Student’s t-test
(**Pp0.01). (b) Clonogenic assay of Foxm1 / and WT MEFs were either non-radiated or exposed to 5Gy of g-irradiation. (c) SAb-gal staining
of Foxm1 / and WT MEFs treated with 0, 20 and 40 nM of epirubicin. 15 days after treatment, cells were stained for SAb-gal activities.
(d) SAb-gal staining of Foxm1 / and WT MEFs treated with g-irradiation (0 and 5Gy). The graphs c and d show the percentage of
SAb-gal-positive cells as measured from five different fields from two independent experiments. Bars represent average±s.d. Statistical
significance was determined by Student’s t-test (**Pp0.01, significant; n.s., non-significant).
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TERT48 human ﬁbroblasts (Supplementary Figure S5). Furthermore,
the NBS1 mRNA was also downregulated after FOXM1 depletion
in the breast cancer cell lines, MDA-MB-231 and ZR-75-1 cells
(Supplementary Figure S5). To conﬁrm further that FOXM1
modulates ATM activity through controlling NBS1 expression, we
examined the expression of these early DNA damage sensor
proteins in WT and Foxm1 / MEFs following epirubicin
treatment (Figure 5a; Supplementary Figure S6). Consistent with
results from the breast cancer cell lines, NBS1 and P-NBS1
accumulated with similar kinetics as FOXM1 in WT MEFs following
epirubicin treatment, but were barely detectable in Foxm1 /
MEFs. By contrast, RAD50 and MRE11 were expressed at only
marginally lower levels in Foxm1 / MEFs compared with WT
MEFs. The western blot results also showed that although ATM
expressed at comparable levels in WT and Foxm1 / MEFs, P-ATM
was induced by epirubicin and expressed at much higher levels
in WT compared with Foxm1 / MEFs. qRT–PCR analysis also
indicated that upon epirubicin treatment the NBS1 and FOXM1
mRNA displayed similar kinetics in both WT and Foxm1 / MEFs,
further conﬁrming FOXM1 regulates NBS1 expression (Figure 5b).
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Figure 2. Knockdown of FOXM1 suppresses growth and induces senescence in MCF-7 and MCF-7EpiR cells. (a) MCF-7 and (b) MCF-7EpiR were
transfected with NS (non-targeting) siRNA or FOXM1 siRNA. Twenty-four hours after transfection, cells were seeded in six-well plates, treated
with epirubicin, grown for 15 days and then stained with crystal violet (left panel). The results (right panel) represent average of three
independent experiments±s.d. Statistical significance was determined by Student’s t-test (*Pp0.05, **Pp0.01, ***Pp0.005; n.s., non-
significant). In parallel, (c) MCF-7 and (d) MCF-7EpiR transfected with NS siRNA or siFOXM1 were seeded in six-well plates, treated with
epirubicin. Five days after treatment, cells were stained for SAb-gal activity. The graphs c and d show the percentage of SAb-gal-positive cells
as measured from five different fields from two independent experiments. Bars represent average±s.d. Statistical significance was determined
by Student’s t-test (*Pp0.05, **Pp0.01, ***Pp0.005, significant; n.s., non-significant).
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Notably, the slight discrepancies between FOXM1 and NBS1
protein and RNA levels can be due to the fact that both
FOXM1 and NBS1 expression as well as activity are also regulated
by post-transcriptional mechanisms.17,19,20 Nevertheless, together
these ﬁndings led us to postulate that FOXM1 may target NBS1
expression at the transcriptional level to enhance DNA damage
repair signalling and genotoxic drug resistance.
FOXM1 modulates NBS1 expression and ATM phosphorylation
We next overexpressed FOXM1 in the MCF-7 cells and examined
its effects on the NBS1 expression and ATM activity. The result
showed that overexpression of FOXM1 caused an induction
of NBS1 levels and ATM phosphorylation in MCF-7 cells
(Figure 6a; Supplementary Figure S7), further conﬁrming that
FOXM1 regulates NBS1 expression and thus MRN complex
formation to promote ATM activation and phosphorylation. It is
notable that despite FOXM1 overexpression, NBS1 levels
decreased after 48 h of epirubicin treatment, probably because
both FOXM1 and NBS1 are also regulated at post-transcriptional
levels in response to epirubicin.19 We next studied the effects
of NBS1 depletion in the resistant MCF-7EpiR cells (Figure 6b).
Knockdown of NBS1 expression by siRNA did not affect
FOXM1, RAD50 and MRE11 expression but resulted in a down-
regulation of P-ATM and P-NBS expression. We also showed
that the NBS1 is required for ATM activition in response to
epirubicin by demonstrating that reconstituting NBS1 expression
can restore ATM activity and phosphorylation in response to
epirubicin in the NBS1-deﬁcient NBS1-LBI cells (Supplementary
Figure S8).
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Figure 3. FOXM1 depletion in MCF-7 cells causes the accumulation of significantly higher numbers of gH2AX foci in response to g-irradiation.
(a) MCF-7 and (b) MCF-7EpiR were transfected with NS siRNA or FOXM1 siRNA. Twenty-four hours after transfection, cells cultured on chamber
slides were either non-radiated or exposed to 5Gy of g-irradiation for 24, 48 and 72h. Cells were then fixed and immunostained for gH2AX foci
(green). Nuclei were counterstained with 40-6-diamidino-2-phenylindole (DAPI; blue). Images were acquired with Leica TCS SP5 ( 63
magnification). For each time point, images of at least 100 cells were captured and used for quantification of gH2AX foci number. Results
represent average of three independent experiments±s.d. Statistical analyses were conducted using Student’s t-tests against the
correspondent time point (**Pp0.01, significant; n.s., non-significant).
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FOXM1 regulates NBS1 expression through a forkhead response
element (FHRE) in its promoter
We next investigated if the regulation of NBS1 by FOXM1 is at the
promoter level. To this end, MCF-7 cells were transiently co-
transfected with the FOXM1 expression construct and a luciferase
reporter gene under the control of either a human NBS1 WT or a
mutant (mut) NBS1 (1.5 kbp) promoter with a putative FHRE
( 78 bp) mutated (Figure 6c).21 We observed the (WT) NBS1
promoter activity was augmented by FOXM1 in a dose-dependent
manner, whereas the mut NBS1 promoter had lower basal
promoter activity and was not inducible by FOXM1 (Figure 6c).
Collectively, these results suggest that FOXM1 is able to
transactivate NBS1 gene through the FHRE located at position
 78 bp, providing evidence that NBS1 is a direct target gene of
FOXM1. To conﬁrm further that FOXM1 binds to the FHRE of the
endogenous NBS1 promoter in vivo, we studied the occupancy of
the FHRE region of the NBS1 promoter by FOXM1 using chromatin
immunoprecipitation with and without FOXM1 transfection in the
MCF-7 cells and before and after 16 h epirubicin treatment in the
MCF-7EpiR cells. The chromatin immunoprecipitation analysis
showed that FOXM1 is recruited to the endogenous FHRE in both
the MCF-7 and MCF-7EpiR and its binding to the FHRE increases in
response to epirubicin (Figure 6d). Together, these ﬁndings
indicate that NBS1 is a direct in vivo transcriptional target of
FOXM1.
Correlation between NBS1 and FOXM1 expression in breast cancer
samples
After establishing that NBS1 is a direct transcriptional target of
FOXM1 in breast cancer and ﬁbroblast cell lines, the correlation of
FOXM1 and NBS1 expression were assessed by immunohisto-
chemistry in breast cancer samples from 116 patients
(Figure 7a).22 FOXM1 and NBS1 staining were detected in both
nuclear and cytoplasmic compartments. Statistical analysis of the
expression patterns revealed that there was a strong and
signiﬁcant correlation between FOXM1 nuclear staining and
total NBS1 staining ((Pearson coefﬁcient¼ 0.318, P¼ 0.002),
providing further physiological evidence that FOXM1 regulates
NBS1 expression in breast cancer patient samples (Figure 7a)). In
addition, there was also a trend linking high NBS1 nuclear
localization expression to poor survival (P¼ 0.164 for overall
survival, log-rank test, Kaplan–Meier estimate analysis), which by
multivariate Cox regression analysis, when adjusted by patients’
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transcript levels (normalized against L19 mRNA levels). Bars represent the meanþ s.d. of three independent experiments. (c, d) MCF-7 and
MCF7EpiR cells were transfected with either NS siRNA or FOXM1 siRNA. Twenty-four hours after transfection, the cells were either untreated or
treated with 1mM epirubicin for 24 h. (c) The protein expression was determined by western blot analysis using antibodies against FOXM1,
NBS1, P-NBS1, RAD50, MRE11, P-ATM, ATM, P-CHK2,CHK2 and b-tubulin. (d) FOXM1, NBS1, MRE11 and RAD50 transcripts were next analysed
by qRT–PCR in the untreated cells (all gene transcripts were normalized against L19). Statistical significance was determined by Student’s t-test
(**Pp0.01, ***Pp0.005, significant; n.s., non-significant).
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T-stage and lymph-node involvement was signiﬁcantly correlated
with poorer survival (relative risk (RR)¼ 2.869, P¼ 0.048;
Supplementary Figure S9). Further analysis of FOXM1 and NBS1
mRNA transcript expression in another previously published
cohort (2878 breast cancer patients)23 revealed that high FOXM1
and NBS1 mRNA expression levels are very signiﬁcantly associated
with poor survival (Po0.0001 and P¼ 0.0012, respectively, for
overall survival, Kaplan–Meier analysis; Supplementary Figure S10).
The signiﬁcance of NBS1 in survival analyses suggests direct
involvement of NBS1 in regulating cell senescence and DNA
damage repair in genotoxic drug response.
NBS1 depletion induces senescence-associated phenotypes in
MCF-7 breast cancer cells
Given that FOXM1 is involved in DNA damage-induced senes-
cence after long treatments with low levels of genotoxic agents
and also controls NBS1 expression, we next explore the role of
NBS1 in genotoxic drug-induced senescence, we next studied the
effects of NBS1 depletion on the long-term viability of MCF-7
and MCF-7EpiR cells by clonogenic assays (Figure 7b). Like
FOXM1, NBS1-knockdown sensitized MCF-7 and MCF-7EpiR cells
to long-term proliferative arrest following treatment with epir-
ubicin (Figure 7b). Consistently, NBS1 knockdown in MCF-7 and
MCF-7EpiR cells also enhanced the number of cells exhibiting SAb-
gal activity and morphology at 0 and 10 nM epirubicin (Figure 7c).
These ﬁndings strongly suggest that NBS1 protects MCF-7 and
MCF-7EpiR cells from entering senescence.
NBS1 and FOXM1 are required for HR repair
We have shown previously that FOXM1 is essential for HR but not
non-homologous end joining DNA repair.17 We next analysed the
role of NBS1 and FOXM1 in DSB repair using HeLa cell lines
harbouring an integrated direct repeat green ﬂuorescent protein
(DR-GFP) reporter for HR.24,25 The I-SceI expression plasmid was
cotransfected into DR-GFP HeLa cells with the NS, FOXM1 or NBS1
siRNA and the percentage of GFP-positive cells assayed by ﬂow
cytometry (Supplementary Figure S11). Knockdown of NBS1 or
FOXM1 using siRNA signiﬁcantly decreased the number of GFP-
positive cells in comparison with NS control siRNA in the HR DR-
GFP reporter system (54.0 and 67.6%, respectively; Figure 8a).
Conversely, overexpression of NBS1 and FOXM1 signiﬁcantly
increased the DSB repair via HR by 82.9% and 87.3%, respectively
(Figure 8a). These observations indicate that similar to FOXM1,
NBS1 contributes to HR-directed DSB repair. To investigate the
functional relationship between NBS1 and FOXM1 in HR-directed
DSB repair, we next examined the effects of NBS1 depletion in the
background of FOXM1 overexpression using DR-GFP HeLa
reporter system. The results showed that the HR activity after
NBS1 knockdown and FOXM1 overexpression (49.4%) was not
signiﬁcantly higher than NBS1 depletion alone, indicating that the
function of FOXM1 to direct HR repair is linked to NBS1.
Ectopic expression of NBS1 in Foxm1 / MEFs abrogates the
accumulation of gH2AX foci
Finally, to demonstrate that the downregulation of NBS1 expres-
sion in FOXM1-depleted cells is responsible for the accumulation of
senescence-associated gH2AX foci upon epirubicin treatment, we
next determined whether overexpression of NBS1 in Foxm1 /
MEFs is able to alleviate the accumulation of gH2AX foci particularly
at the longer times of 24, 48 and 72h (Figure 8b). Strikingly,
Foxm1 / MEFs co-transfected with pmCherry (red) and NBS1
displayed signiﬁcantly fewer foci compared with the adjacent/
neighbouring non-transfected cells at the longer time points. The
overexpression of NBS1 had the same effects as reconstituting
Foxm1 / MEFs with pmCherry-FOXM1 (Supplementary
Figure S12). In contrast, Foxm1 / MEFs transfected with the
empty-pmCherry control have similar kinetics for senescence-
associated gH2AX foci accumulation as the non-transfected cells
(Supplementary Figure S12). Taken together, these ﬁndings further
suggest that the role of FOXM1 to repair DSB-DNA damage is
related to its ability to control NBS1 expression.
DISCUSSION
Senescence is an intrinsic cellular response that induces irrever-
sible cell-cycle arrest. Cellular senescence restricts unlimited cell
proliferation and has a critical role in both ageing as well as
tumour suppression. It was ﬁrst observed in cell culture, but has
also been proved to exist in vivo. It is generally perceived that
most cancer as well as tissue culture cells have overcome cellular
senescence and achieved immortality.12 However, the present
study shows that breast cancer cell lines as well as immortalized
MEFs can be induced into entering cellular senescence by DNA-
damaging agents, including epirubicin and ionizing irradiation.
Notably, the doses of DNA-damaging agents required for
triggering senescent phenotypes in these cells are substantially
lower than that required to induce short-term proliferative arrest
and cell death,15,17 but are in line with the physiological doses
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used in the clinic,26 raising the possibility that cellular senescence
may be the predominant mechanism of action for the genotoxic
anti-cancer agents.
FOXM1 has been implicated in genotoxic drug resistance but its
role and mechanism of action are still not yet fully understood. We
show here that FOXM1 has a central role in modulating DNA
damage-induced senescence and thus genotoxic agent resistance.
Depletion of FOXM1 sensitized MCF-7 breast cancer cells as well as
MEFs into entering epirubicin-induced senescence, as revealed by
the loss in long-term cell proliferation ability, the time-dependent
accumulation of gH2AX foci, and induction of SAb-gal activity and
cell morphology. Conversely, reconstitution of FOXM1 in FOXM1-
deﬁcient MEFs alleviated the accumulation of senescence-
associated gH2AX foci. NBS1 is a component of the MRE11/
RAD50/NBS1 complex, which has a central role in processing
damaged DNA for repair and in promoting ATM-dependent DNA
damage response signalling.27 In deﬁning FOXM1 targets that
have a role in genotoxic agent-induced senescence, we identiﬁed
NBS1 as a key FOXM1 target involved in DNA damage repair,
genotoxic drug resistance and DNA damage-induced senescence.
At the molecular level, we found that FOXM1 regulates NBS1 at
the protein and mRNA levels through an FHRE on its promoter in
response to epirubicin treatment. Consistently, overexpression of
FOXM1 augmented NBS1 expression and ATM phosphorylation,
whereas FOXM1 depletion reduced NBS1 expression and ATM
phosphorylation upon epirubicin treatment in breast cancer cells.
Like FOXM1, NBS1 was overexpressed in the drug-resistant MCF-
7EpiR cells and its expression level was low but inducible by
epirubicin in MCF-7 cells. We also found that NBS1, but not MRE11
and RAD50, levels were modulated by FOXM1 and in response to
epirubicin, suggesting that NBS1 is limiting for the formation of
the MRN complex and that its level sets the threshold for DNA
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repair activity. Collectively, these ﬁndings suggest that FOXM1
increases NBS1 expression and ATM phosphorylation, possibly
mediated by increasing the levels of the MRN complex. Consistent
with this idea, the loss of P-ATM induction upon epirubicin
treatment in the NBS1-deﬁcient NBS1-LBI human ﬁbroblasts can
be rescued by NBS1 reconstitution.
Resembling FOXM1, NBS1 depletion also rendered MCF-7 and
MCF-7EpiR cells more sensitive to epirubicin-induced cellular
senescence. In agreement, the DNA repair defect and epirubicin-
induced senescence phenotypes in FOXM1-deﬁcent cells could be
effectively rescued by overexpression of NBS1. Consistently,
overexpression of NBS1 and FOXM1 similarly enhanced and their
depletion downregulated HR repair. Importantly, overexpression
of FOXM1 failed to augment HR activity in the background of
NBS1 depletion, demonstrating that NBS1 is indispensable for the
HR function of FOXM1. Consistent with our ﬁndings, a role in DNA
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damage-induced senescence-associated inﬂammatory cytokine
secretion has previously been suggested for NBS1.28 The
physiological relevance of the regulation of NBS1 expression by
FOXM1 is further underscored by the strong and signiﬁcant
correlation between nuclear FOXM1 and total NBS1 expression in
breast cancer patient samples. Furthermore, both FOXM1 and
NBS1 mRNA expression are signiﬁcantly associated with poor
prognosis in breast cancer, supporting a physiological role of
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FOXM1 and its target NBS1 in genotoxic drug resistance. In
summary, we identify NBS1 as a key FOXM1 target gene involved
in DNA damage response, genotoxic drug resistance and DNA
damage-induced senescence. Our data also suggest that the
FOXM1-NBS1 axis can be a reliable prognostic marker and a viable
target for therapeutic intervention for targeting cancer and for
overcoming genotoxic agent resistance in cancer.
MATERIALS AND METHODS
Cell culture
The human breast carcinoma MCF-7, MDA-MB-231 and ZR-75-1 cell lines
were originated from the American Type Culture Collection (Manassas, VA,
USA) and were acquired from the Cell Culture Service, Cancer Research UK,
where it was tested and authenticated. MEFs isolated from Foxm1 / and
WT mice have been previously described.29 The 48BRhtert and NBS1-LBI
human ﬁbroblasts have also been described.30 The HeLa DR-GFP reporter
cells were a gift from Dr Maria Jasin (Memorial Sloan-Kettering Cancer
Center, New York, USA).24,31 All cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal calf serum, 2mM glutamine,
100U/ml penicillin/streptomycin and maintained at 37 1C in a humidiﬁed
incubator with 10% CO2. The MCF-7Epi
R was maintained in 10mmol/l
Epirubicin (Medac, Hamburg, Germany), as previously described.32
Plasmids
The pFlag-Nbs1 and the pcDNA3-FOXM1 have been described.16,33 The
pmCherry-FOXM1 was generated by cloning the full-length FOXM1 cDNA
from pcDNA3-FOXM1 into the EcoRI and BamHI sites of the pmCherry-N1
vector (Clontech, Mountain View, CA, USA) and the pCMV-I-SceI has been
described.24,31 The WT NBS1 promoter luciferase reporter construct,
pNBSLuc1500, has previously been described.21 Expression plasmid
transfections were performed with FuGENE 6 (Roche, Indianapolis, IN,
USA) according to the manufacturer’s recommendations. See also
Supplementary Materials and Methods for mut NBS1 promoter generation.
Luciferase reporter assay
Cells were co-transfected with the human NBS1 promoter luciferase
reporter and transfection control Renilla (pRL-TK; Promega, Southampton,
UK) constructs using FuGENE6 (Roche). For promoter analysis, 24 h
after transfection, cells were then collected, washed twice in PBS and
harvested for ﬁreﬂy/Renilla luciferase assays using the Dual-Glo Luciferase
reporter assay system (Promega, Madison, WI, USA) according to
manufacturer’s instruction. Luminescence was then read using the 9904
TOPCOUNT Perkin Elmer (Beaconsﬁeld, UK) plate reader.
gH2AX immunoﬂuorescent staining and foci quantiﬁcation
Cells grown on chamber culture slides were ﬁxed in 4% paraformaldehyde
(Thermo Scientiﬁc, Rockford, IL, USA) for 15min followed by permeabiliza-
tion for 10min with 0.2% Triton X-100 in PBS, and blocking with 5% goat
serum for 30min at room temperature. The slides were incubated with
primary antibody anti-gH2AX Ser139 (20E3; Cell Signaling, Danvers, MA,
USA) overnight at 4 1C. See also Supplementary Materials and Methods.
SAb-gal assay
Cells were seeded in six-well plates at a density of approximately 20 000
cells/well before treatment with epirubicin or g-irradiation for 48 h. After
culture for a further 5 days, cells were ﬁxed and stained using a
Senescence b-Galactosidase Staining Kit #9860 purchased from Cell
Signalling Technology (Beverley, MA, USA). Plates were incubated
overnight at 37 1C in a dry incubator (no CO2). Cells were then detected
for blue staining under a bright-ﬁeld microscope. The percentage of SAb-
gal-positive cells was calculated by counting the cells in ﬁve random ﬁelds.
Western blotting and antibodies
Western blotting was performed on whole-cell extracts by lysing cells in
buffer as described.34 Antibodies FOXM1 (C-20), b-tubulin (H-235) and
I-SceI were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Antibodies for P-ATM (Ser1981; MAB3806), P-H2AX (Ser139; JBW301)
were obtained from Upstate (Millipore, Oxford, UK). The NBS1 (3002)
and P-NBS1 antibodies were purchased from Cell Signaling Technology
(New England Biolabs Ltd. Hitchin, UK). Total ATM antibody was obtained
from Calbiochem (Millipore, Oxford, UK), and MRE11 and RAD50 were from
Novus Biologicals (Cambridge, UK). Primary antibodies were detected
using horseradish peroxidase-linked anti-mouse or anti-rabbit conjugates
as appropriate (Dako, Glostrup, Denmark) and visualized using the ECL
detection system (Amersham Biosciences, Pollards Wood, UK).
Quantitative real-time PCR (qRT–PCR)
Total RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden,
Germany). Complementary DNA generated by Superscript III reverse
transcriptase and oligo-dT primers (Invitrogen, Paisley, UK) was analysed by
qRT–PCR as described.35 Transcript levels were quantiﬁed using the
standard curve method. For PCR-primer sequences, see Supplementary
Materials and Methods.
Gene silencing with siRNAs
For gene silencing, cells were transiently transfected with siRNA SMART-
pool reagents purchased from Thermo Scientiﬁc Dharmacon (Lafayette,
CO, USA) using Oligofectamine (Invitrogen) according to the manu-
facturer’s instructions. SMARTPool siRNAs used were: siRNA FOXM1
(L-009762-00), siRNA NBS1 (L-009641-00) and the NS control siRNA,
conﬁrmed to have minimal targeting of known genes (D-001810-10-05).
Two-step cross-linking chromatin immunoprecipitation
Dual cross-linking chromatin immunoprecipitation using formaldehyde
and di-(N-succimidyl) glutarate was performed on MCF-7 and MCF-7EpiR
cells, as described.36 See also Supplementary Materials and Methods.
Clonogenic assay
See Supplementary Materials and Methods.
Statistical analysis
Statistical analysis was performed using the SPSS programme version 17.
The correlation between FOXM1 and NBS1 expression was analysed by
bi-variate Pearson Correlation analysis. Survival analysis was assessed by
Kaplan–Meier analysis using log-rank test. P values of less than or equal to
0.05 were considered statistically signiﬁcant. The statistical signiﬁcance
of differences between the means of two groups was evaluated by
paired Student’s t-test using the Microsoft Excel programme and
considered signiﬁcant when *Pp0.05s, **Pp0.01 and ***Pp0.005. n.s.
for non-signiﬁcant.
HR repair assays
HR assays were performed as previously described.24,31 Analysis was
conducted using a FACSCanto analyzer. GFP-ﬂuorescence was analysed
using Cell Diva software (Becton Dickinson, Oxford, UK).
Tissue microarray, immnohistochemistry and staining scoring
See Supplementary Materials and Methods
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